Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Liu

Showing results (291-300 of 361) with videos related to

Pageof 37
Sort By:
Journal of Neuroimmunology|October 12, 2016
Isoaspartylation appears to trigger small cell lung cancer-associated autoimmunity against neuronal protein ELAVL4Mario A Pulido, Meleeneh Kazarian DerHartunian, Zhenxia Qin, et al.
Circulation Research|October 13, 2007
Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemiaMarta Bosch-Marce, Hiroaki Okuyama, Jacob B Wesley, et al.
American Journal of Clinical Oncology|February 21, 2018
Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 StudyRoger B Cohen, Jean-Pierre Delord, Toshihiko Doi, et al.
Cancer Immunology Research|January 26, 2024
Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with CancerHewitt Chang, Jaqueline Marquez, Brandon K Chen, et al.
Clinical Lung Cancer|November 21, 2021
The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung CancerMisako Nagasaka, Vijendra Singh, Yasmine Baca, et al.
Cell Genomics|March 14, 2024
Modular vector assembly enables rapid assessment of emerging CRISPR technologiesAbby V McGee, Yanjing V Liu, Audrey L Griffith, et al.
ESMO Open|June 25, 2025
Correlation between treatments and outcomes of patients with EGFR-mutated non-small-cell lung cancer that transitioned into small-cell lung cancer: an international retrospective studyC Catania, S V Liu, M Garassino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2021
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)Stephen V Liu, Martin Reck, Aaron S Mansfield, et al.
Cancer|February 28, 2026
Multiomic characterization of small cell lung cancer: Real-world insights into therapeutic opportunitiesSonam Puri, Andrew Elliott, Abdul Rafeh Naqash, et al.
Cancer Cell|November 22, 2024
Mutation burden and anti-PD-1 outcomes are not universally associated with immune cell infiltration or lymphoid activationDavid Hsiehchen, Andrew Elliott, Joanne Xiu, et al.
Pageof 37

Showing results (291-300 of 361) with videos related to

Sort By:
Pageof 37
Journal of Neuroimmunology|October 12, 2016
Isoaspartylation appears to trigger small cell lung cancer-associated autoimmunity against neuronal protein ELAVL4Mario A Pulido, Meleeneh Kazarian DerHartunian, Zhenxia Qin, et al.
Circulation Research|October 13, 2007
Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemiaMarta Bosch-Marce, Hiroaki Okuyama, Jacob B Wesley, et al.
American Journal of Clinical Oncology|February 21, 2018
Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 StudyRoger B Cohen, Jean-Pierre Delord, Toshihiko Doi, et al.
Cancer Immunology Research|January 26, 2024
Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with CancerHewitt Chang, Jaqueline Marquez, Brandon K Chen, et al.
Clinical Lung Cancer|November 21, 2021
The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung CancerMisako Nagasaka, Vijendra Singh, Yasmine Baca, et al.
Cell Genomics|March 14, 2024
Modular vector assembly enables rapid assessment of emerging CRISPR technologiesAbby V McGee, Yanjing V Liu, Audrey L Griffith, et al.
ESMO Open|June 25, 2025
Correlation between treatments and outcomes of patients with EGFR-mutated non-small-cell lung cancer that transitioned into small-cell lung cancer: an international retrospective studyC Catania, S V Liu, M Garassino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2021
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)Stephen V Liu, Martin Reck, Aaron S Mansfield, et al.
Cancer|February 28, 2026
Multiomic characterization of small cell lung cancer: Real-world insights into therapeutic opportunitiesSonam Puri, Andrew Elliott, Abdul Rafeh Naqash, et al.
Cancer Cell|November 22, 2024
Mutation burden and anti-PD-1 outcomes are not universally associated with immune cell infiltration or lymphoid activationDavid Hsiehchen, Andrew Elliott, Joanne Xiu, et al.
Pageof 37